Shockwave Medical Appoints Nick West as Associate Chief Medical Officer

1 year ago

Nick West, MD, joins Shockwave from Abbott VascularSANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:…

LifeSci Partners Expands Presence in Asia Pacific with Appointment of Jeff Seo

1 year ago

NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- LifeSci Partners, the leading provider of strategic advisory services to the global…

Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial

1 year ago

Fort Lee, NJ, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage…

Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors

1 year ago

BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Sensorium Therapeutics (Sensorium), a biotechnology company translating insights from nature and human experience…

Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan

1 year ago

RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading…

Kane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit Facility

1 year ago

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Sept. 12, 2023 (GLOBE…

Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity

1 year ago

MORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced…

Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer

1 year ago

CLEVELAND, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Madhav Vasanthavada, Ph.D.,…

Altimmune Announces Completion of Dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight

1 year ago

Top-line 48-week results from the trial expected Q4 2023GAITHERSBURG, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT),…

Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results

1 year ago

HAMILTON, BERMUDA, Sept. 12, 2023 (GLOBE NEWSWIRE) --  Company hosts 1H 2023 Financial Results and Business Update call today at 8…